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The Bell Wing at Toronto General Hospital has long gone, but in the Fall of 1982, that was where I began my journey into human microbiome and probiotic 
research. Stimulated by mentor Dr. Andrew Bruce, Head of 
Urology, I asked the question: “Were there beneficial bacte-
ria in the urogenital tract and if they help prevent infection, 
could they be replenished to reset an infectious state back to 
normal?”  Thirty-three years later, this is arguably the hottest 
field of medicine, and one that will transform its practice for 
years to come. 
Humans have evolved from microbes, so it should be no 
surprise to find these organisms playing a key role in health. 
But, who would have thought they would be living in the 
brain,1 breast tissue,2 stomach,3 in some sort of suspended 
state, and, through the gut, influencing metabolism,4 cardi-
ac health,5,6 anxiety7 and bone density,8 to name a few? Who 
would have imagined being able to identify over 200 species 
present in any given niche within hours using a device the 
size of a Mars Bar?9 And to be able to detect disease through 
metabolic by-products from these microbes?10 A mere eleven 
years ago, the word probiotic was barely in the medical lan-
guage, and viewed by some as snake oil: today, its market size 
is around $30 billion. The transfer of feces from human do-
nor to recipient was unimaginable not long ago, but to find 
that it has a 90% cure rate of deadly Clostridium difficile infec-
tion11 and to consider doing this to prevent obesity or delay 
mental illness12 would have seemed draconian just ten years 
ago. Yet, here we are today recognizing that microbes play 
an integral part in health and disease. Indeed, potentially in 
the determinants of health and their developmental origins. 
Where could the future possibly take us?
These discoveries are playing havoc with traditional prac-
tices and systems we established within our society. From 
the early 20th Century, regulatory agencies were set up and 
instructed to adjudicate that drugs could prevent, treat and 
cure disease. Fast forward to the present, it seems absurd 
to suggest that microbial-containing food and supplements 
need to be defined as drugs that must be prescribed to treat, 
prevent and potentially even cure some diseases. The FDA, 
for example, clearly demands that this should happen.13 Not 
only that, the system of registering bacterial strains as part 
of regulatory procedures does not allow for depositing strain 
combinations, even though once separated from each other, 
such strains die, thereby defeating the whole purpose of de-
position. 
The education of medical doctors and other healthcare 
professionals has been streamlined in recent years, with 
teaching the importance of beneficial microbes all but de-
leted. If our healthcare specialists don’t understand this area, 
how can we ask them to manage health issues associated with 
microbes, and recommend interventions and approaches 
outside of drug prescriptions? Continual medical education 
and conferences might help, but they often convey opinions 
rather than establish guidelines and basic training. With com-
panies creating diagnostic systems to relay microbiome and 
metabolome data,10 practitioners must be able to interpret 
them and consider the ethical implications of disclosing the 
information.14 
If the composition of the gut microbiome influences drug 
adsorption,15 should all drugs not be re-tested against a pa-
tient’s microbes? The implications are enormous, but this 
aspect of personalized medicine is clearly on the horizon. 
Probiotics have been shown to augment the effects of some 
drugs,16,17 but how do physicians write a script for a probiotic 
food? The creation of Guidelines that outline probiotic prod-
ucts that have been at least clinically tested18 certainly helps 
consumers plod through the multitude of products available, 
and recognize those that have not been tested for effective-
ness in humans. 
As the microbiome appears to form into an ‘adult’ compo-
sition by around age three, and as many diseases are already 
conditioned by then, the question of ‘programming’ the mi-
crobiome during fetal and early life must be considered. The 
best way of doing this is far from understood, but manipula-
tion of one form or another is already taking place through 
the placenta,19 breast milk,20 and probiotic infant formula.21 
Longitudinal studies are needed to understand this crucial 
stage in life, yet Canada, the European Union and USA have 
ceased funding large microbiome programs, and pay lip ser-
vice to the funding of probiotic research and indeed research 
on what makes people healthy. This is ironic considering the 
funders are institutes of ‘health’. 
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While surgery and other invasive interventions will be nec-
essary long into the future, many other aspects of medicine 
will change dramatically in the next twenty years. Interpre-
tation of data, whether acquired in centres or by individu-
als, will become paramount, and a holistic understanding of 
anatomy and physiology, nutrition and the microbiome will 
be essential. Metchnikoff directed us to ask why Bulgarian 
peasants lived so long22 and how fermented foods were as-
sociated with it. The key to a long, healthy life likely does lie 
in our food and microbes - we just need to understand how 
best to align them, in some cases also taking into consider-
ation our genetic endowment. Time will tell how quickly we 
embrace the future.
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